It is a paper private limited company based in Serilingampally, Telangana, India, established in 2024.
2024 | Serilingampally, Telangana, India | ActiveMorepen Proprietary Drug Research Private Limited, a active private limited company, was established on 16 February 2024 in Serilingampally, Telangana, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21000TS2024PTC182254. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Shalu Suri (Managing Director), Sanjay Suri (Director), Ravi Shekar Ananthula (Director). Past directors included Shalu Suri, Deeparani Gopagoni. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Aspire-Tbi, School Of Life Sciences, Hcu, 3Rd Floor, Tbi, Hyderabad, Serilingampally, Telangana, 500046.
U21000TS2024PTC182254
182254
16 February 2024
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Morepen Proprietary Drug Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shalu Suri | Managing Director | 16 Feb 2024 | Current |
| Sanjay Suri | Director | 16 Feb 2024 | Current |
| Ravi Shekar Ananthula | Director | 16 Feb 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Mar 2025 | Past |
| Pramod Abcsdd | Individual Subscriber | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Morepen Proprietary Drug Research's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Morepen Proprietary Drug Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Morepen Proprietary Drug Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Morepen Proprietary Drug Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Morepen Proprietary Drug Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Morepen Proprietary Drug Research Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Morepen Proprietary Drug Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.
Shalu Suri was appointed as a Managing Director was appointed as a Managing Director on 16 Feb 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
Progress on Sanjay Suri was appointed as a Director was appointed as a Director on 16 Feb 2024 & has been associated with this company since 1 year 10 months . was documented.
Ravi Shekar Ananthula was appointed as a Director was appointed as a Director on 16 Feb 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
Progress on Morepen Proprietary Drug Research Private Limited was registered on 16 Feb 2024 with Roc Hyderabad & aged 1 year 10 months as per MCA records. was documented.
The CIN of Morepen Proprietary Drug Research Private Limited is U21000TS2024PTC182254.
Morepen Proprietary Drug Research Private Limited is headquartered at Aspire-Tbi, School Of Life Sciences, Hcu, 3Rd Floor, Tbi, Hyderabad, Serilingampally, Telangana, 500046.
Morepen Proprietary Drug Research Private Limited was incorporated on 16 February 2024.
The current directors of Morepen Proprietary Drug Research Private Limited are
The primary industry of Morepen Proprietary Drug Research Private Limited is Paper.
Morepen Proprietary Drug Research Private Limited is unlisted.
The authorized capital of Morepen Proprietary Drug Research Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX